Published in Surg Clin North Am on June 01, 1992
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation (1997) 4.54
Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg (2001) 2.80
Quantitative analysis of reproducible changes in high-voltage electrophotography. J Altern Complement Med (2001) 2.29
Implantable left ventricular assist devices. N Engl J Med (1998) 2.07
Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg (1995) 1.96
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95
Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest (1996) 1.81
A regional survey of health insurance coverage for complementary and alternative medicine: current status and future ramifications. J Altern Complement Med (2001) 1.77
Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg (2001) 1.68
Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65
Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63
Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg (1998) 1.58
Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation (1995) 1.49
The effects of self-hypnosis on quality of life following coronary artery bypass surgery: preliminary results of a prospective, randomized trial. J Altern Complement Med (1995) 1.49
Preservation of anterior leaflet chordae tendineae during mitral valve replacement. Ann Thorac Surg (1994) 1.47
Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg (1997) 1.47
Surgical management of cardiac pheochromocytoma. Resection versus transplantation. Ann Surg (1995) 1.42
Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass. Crit Care Med (2000) 1.40
Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg (1994) 1.40
Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure. J Thorac Cardiovasc Surg (1998) 1.39
Discrepancy between claimed field flux density of some commercially available magnets and actual gaussmeter measurements. Altern Ther Health Med (2001) 1.39
Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation (2000) 1.32
Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg (1999) 1.28
Experience with heart transplantation for cardiac tumors. J Heart Lung Transplant (1995) 1.28
Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med (1997) 1.24
Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation (2000) 1.21
Novel technique to repair type A acute aortic dissection in patients with a left ventricular assist device. Ann Thorac Surg (2001) 1.21
A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation (1997) 1.20
Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg (1999) 1.16
Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation. J Heart Lung Transplant (1996) 1.14
Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction. Ann Thorac Surg (2001) 1.14
De novo solid malignancies after cardiac transplantation. Ann Thorac Surg (1995) 1.13
Changes in type I collagen following laser welding. Lasers Surg Med (1992) 1.12
A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg (2000) 1.11
Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest (1994) 1.10
Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation (1994) 1.09
Hepatobiliary complications of polyarteritis nodosa. Arch Surg (1991) 1.09
Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation. Proc Natl Acad Sci U S A (1997) 1.08
Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg (2000) 1.08
Influence of steroids on postoperative swelling after facialplasty: a prospective, randomized study. Plast Reconstr Surg (1995) 1.07
Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2000) 1.04
The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant (1997) 1.03
100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg (1999) 1.01
Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation (1999) 1.01
Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation (1998) 1.01
Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance. J Heart Lung Transplant (1999) 1.00
The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci U S A (1994) 0.99
Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation (2001) 0.98
Radical excisional therapy and total cardiac transplantation for recurrent atrial myxoma. Ann Thorac Surg (1995) 0.97
Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet (1999) 0.96
Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol (1997) 0.96
Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant (1996) 0.95
Long-term survival after cardiac retransplantation: a twenty-year single-center experience. J Thorac Cardiovasc Surg (1999) 0.95
Left ventricular volume reduction surgery for heart failure: a physiologic perspective. J Thorac Cardiovasc Surg (2001) 0.94
Transaortic repair of mitral regurgitation. Heart Surg Forum (2000) 0.94
Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. J Thorac Cardiovasc Surg (1998) 0.94
Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant (1998) 0.94
Fungal left ventricular assist device endocarditis. Ann Thorac Surg (2001) 0.94
Enhanced preservation of orthotopically transplanted rat lungs by nitroglycerin but not hydralazine. Requirement for graft vascular homeostasis beyond harvest vasodilation. Circ Res (1995) 0.94
Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury. Cardiovasc Surg (1999) 0.93
Experience with right ventricular assist devices for perioperative right-sided circulatory failure. Ann Thorac Surg (1996) 0.93
Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg (1996) 0.93
Effects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model. Ann Thorac Surg (2000) 0.93
In vitro comparison of thulium-holmium-chromium: YAG and argon ion lasers for welding of biliary tissue. Lasers Surg Med (1989) 0.92
Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation (2001) 0.92
Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. J Thorac Cardiovasc Surg (2000) 0.92
Autologous fibrin glue: production and clinical use. Transfus Med Rev (1996) 0.91
Normalized diastolic properties after left ventricular assist result from reverse remodeling of chamber geometry. Circulation (2001) 0.91
Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. Ann Thorac Surg (2001) 0.90
"Bow-tie" mitral valve repair: an adjuvant technique for ischemic mitral regurgitation. Ann Thorac Surg (1998) 0.89
What do parents need when their infant is a patient in the NICU? Neonatal Netw (1991) 0.89
Development of an infection-resistant LVAD driveline: a novel approach to the prevention of device-related infections. J Heart Lung Transplant (1999) 0.89
Mechanical support for postcardiotomy cardiogenic shock. Semin Thorac Cardiovasc Surg (2000) 0.89
Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg (2001) 0.88
Surgical treatment of atrial fibrillation using radiofrequency energy. Ann Thorac Surg (2001) 0.88
Improved results for postcardiotomy cardiogenic shock with the use of implantable left ventricular assist devices. Ann Thorac Surg (1997) 0.88
Miniature axial flow pump for ventricular assistance in children and small adults. J Thorac Cardiovasc Surg (1996) 0.88
Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment. ASAIO J (1996) 0.87
Quality of life with an implanted left ventricular assist device. Ann Thorac Surg (1997) 0.87
Selective anticoagulation with active site blocked factor IXa in synthetic patch vascular repair results in decreased blood loss and operative time. ASAIO J (1998) 0.86
Inflow valve regurgitation during left ventricular assist device support may interfere with reverse ventricular remodeling. Ann Thorac Surg (1998) 0.86
Welding of gallbladder tissue with a pulsed 2.15 microns thulium-holmium-chromium:YAG laser. Lasers Surg Med (1989) 0.86
Orthotopic heart transplantation in patients with treated malignancies. Am J Cardiol (1995) 0.86
Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant. J Heart Lung Transplant (2000) 0.85
Dye-enhanced laser tissue welding. Lasers Surg Med (1989) 0.85
Evolving costs of long-term left ventricular assist device implantation. Ann Thorac Surg (1997) 0.85
A study of the effect of energy healing on in vitro tumor cell proliferation. J Altern Complement Med (1999) 0.85
Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration. J Cardiothorac Vasc Anesth (1998) 0.85
Outpatient left ventricular assist device support: a destination rather than a bridge. Ann Thorac Surg (1996) 0.85
Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation. Transplantation (1997) 0.85
Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland. J Am Coll Cardiol (2001) 0.84
Left ventricular assist device implantation augments nitric oxide dependent control of mitochondrial respiration in failing human hearts. J Am Coll Cardiol (2000) 0.84
Indications and patient selection for mechanical ventricular assistance. Ann Thorac Surg (2001) 0.84
Asymptomatic microembolism in patients with long-term ventricular assist support. ASAIO J (1997) 0.84